
What Are the Top Questions in ALL?
The HemOnc Pulse
00:00
Treatment Options for Relapse Disease in ALL
The chapter discusses the current treatment options for relapsed disease in acute lymphoblastic leukemia (ALL), including CAR-T therapy, allogeneic transplant, and newer drugs and novel therapies targeting CD-19, CD-22, CD-20, and BCL-2 inhibitors.
Play episode from 22:10
Transcript


